What are the research priorities for optimising the safe and effective use of opioids in Australian general practice?
Australia
consensus
general practice
opioid
research
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
02
07
2022
received:
20
01
2022
accepted:
12
08
2022
pubmed:
7
9
2022
medline:
23
3
2023
entrez:
6
9
2022
Statut:
ppublish
Résumé
Persistent high rates of prescription opioid use and harms remain a concern in Australia, Europe and North America. Research priority setting can inform the research agenda, strategic responses and evidence-based interventions. The objective of this study was to establish research priorities related to the safe and effective use of prescription opioids in general practice. Consumers, clinicians and policy makers were invited to participate in a structured consensus workshop in May 2021. A modified nominal group technique was used to explore research priorities for the safe and effective use of opioids in Australian general practice. Research priorities were identified, consolidated and prioritised using a structured process. Seventeen consumer, medical, pharmacy, nursing, allied health and policy participants generated 26 consolidated priorities across three domains: (i) consumer-focused priorities; (ii) clinician and practice-focused priorities; and (iii) system and policy-focused priorities. The highest ranked research priorities in each of the domains were consumer characteristics that influence opioid prescribing and outcomes, opioid deprescribing strategies, and system-level barriers to prescribing alternatives to opioids, in the consumer, clinician and practice, and system and policy domains, respectively. The priorities reflect opportunities for research priority setting within Australian general practice. The priorities provide a map for future qualitative and quantitative research that will inform safe and effective opioid prescribing.
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
604-613Subventions
Organisme : SN in the recipient of an National Health and Medical Research Council Research Fellowship
ID : 1163961
Organisme : SB is the recipient of an National Health and Medical Research Council Dementia Leadership Fellowship
ID : 1140298
Informations de copyright
© 2022 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.
Références
BMC Musculoskelet Disord. 2019 Feb 13;20(1):74
pubmed: 30760253
Nurse Res. 2014 Jul;21(6):22-7
pubmed: 25059084
JAMA Netw Open. 2020 Dec 1;3(12):e2028392
pubmed: 33289842
Am J Public Health. 1972 Mar;62(3):337-42
pubmed: 5011164
Aust J Gen Pract. 2020 Aug;49(8):530-532
pubmed: 32738870
BMC Fam Pract. 2007 Jul 11;8:40
pubmed: 17625004
Br J Clin Pharmacol. 2018 Jun;84(6):1267-1278
pubmed: 29451672
Drug Alcohol Rev. 2018 Feb;37(2):257-261
pubmed: 28597531
BMC Med Res Methodol. 2019 Dec 28;19(1):243
pubmed: 31883517
Int J Drug Policy. 2019 Dec;74:170-173
pubmed: 31622949
Ann Intern Med. 2015 Feb 17;162(4):295-300
pubmed: 25581341
Drug Alcohol Rev. 2023 Mar;42(3):604-613
pubmed: 36065154
BMJ Open. 2018 Feb 28;8(2):e020870
pubmed: 29490970
Ann Intern Med. 2017 Aug 01;167(3):181-191
pubmed: 28715848
Intern Med J. 2020 Oct;50(10):1185-1191
pubmed: 33111411
Health Promot Int. 2017 Dec 1;32(6):1074-1080
pubmed: 27099240
Int J Environ Res Public Health. 2018 Jul 23;15(7):
pubmed: 30041427
J Subst Abuse Treat. 2019 Aug;103:58-63
pubmed: 31079950
Implement Sci. 2020 Apr 25;15(1):26
pubmed: 32334632
Addiction. 2020 Mar;115(3):451-459
pubmed: 31577369
Res Social Adm Pharm. 2017 May - Jun;13(3):564-574
pubmed: 27374998
NAM Perspect. 2020 Aug 10;2020:
pubmed: 35291734
Milbank Q. 2001;79(2):281-315
pubmed: 11439467
Med J Aust. 2020 Apr;212(7):321-327
pubmed: 32200566
Br J Clin Pharmacol. 2019 Jan;85(1):202-215
pubmed: 30338545
Fam Pract. 1993 Mar;10(1):76-81
pubmed: 8477899
J Opioid Manag. 2019 Jul/Aug;15(4):267-271
pubmed: 31637678
Aust J Gen Pract. 2019 Nov;48(11):789-795
pubmed: 31722467
Pain Med. 2020 Apr 1;21(4):670-676
pubmed: 30938818
Am J Prev Med. 2015 Sep;49(3):409-13
pubmed: 25896191
Ann Intern Med. 2020 Nov 3;173(9):721-729
pubmed: 32805130
JAMA. 2019 Nov 19;322(19):1855-1856
pubmed: 31600366